As UNC geneticist Jonathan Berg gears up to lead a $9.7-million renewal of the NCGENES project, we look at a story from the original study and how it changed the fortunes of a woman from Goldsboro, NC.
Gene Therapy, Genetics, Genome, News, Patient Stories, Research
In two previous studies, University of North Carolina researchers and colleagues linked infant brain anatomy differences to autism diagnoses at age two. Now they show differences in functional connections between brain regions at 6 months to predict autism at age two.
Autism, Brain Health, Children's Health, Mental Health, News, Publications, Research, Studies
The UNC School of Medicine discovery could lead to more effective, personalized treatments for the debilitating gastrointestinal condition.
Genetics, Research
Jennifer Law, MD, director of UNC Children’s Turner Syndrome Program, is working to build awareness of Turner syndrome and show patients and their families that they can overcome their diagnosis.
Genetics, Research, Women's Health
UNC-led global phase-3 clinical trial sets the stage for improved management of a disease that affects nearly 30 million Americans.
Diabetes, Research, Treatment
A new tool will allow David Berkoff, MD, associate professor of orthopaedics, the ability to provide his patients with more accurate diagnoses, closely monitor their recovery and, he says, aid in research.
Orthopedics, Research, Technology
In a double-blinded, randomized study, UNC researchers found that the IQ scores of people who underwent tDCS brain stimulation improved markedly less than did the IQ scores of people in the placebo group.
Neurology, Research, Treatment
Using a weak electric current to alter a specific brain activity pattern, UNC School of Medicine researchers increased creativity in healthy adults. Now they’re testing the same experimental protocol to alleviate symptoms in people with depression.
Mental Health, Neurology, Research, Treatment
In February, UNC neurologist Hae Won Shin, MD, and neurosurgeon Eldad Hadar, MD, were the first in the state to implant the NeuroPace RNS System following the medical device’s recent FDA approval. In clinical trials, the NeuroPace system greatly reduced the number of seizures experienced by patients with severe epilepsy.
Innovation, Neurology, Technology, Treatment
Dr. Harold Pillsbury performed the surgery to implant a newly FDA-approved device that enables wearers to have MRI scans when needed. This was not possible with earlier cochlear implant models.
Hearing, Innovation, Technology
Silymarin or “milk thistle,” a popular herbal dietary supplement that many people take for liver ailments, works no better than placebo in patients with chronic hepatitis C infection.
Chronic Illness, Clinical Trials, Hepatitis C, Hepatology, Nutrition, Treatment, Wellness
